Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
142.20B | 129.29B | 109.33B | 109.64B | 117.22B | 105.74B | Gross Profit |
23.64B | 18.77B | 15.53B | 15.77B | 17.63B | 14.38B | EBIT |
13.51B | 7.83B | 5.71B | 6.62B | 8.40B | 4.88B | EBITDA |
14.28B | 8.93B | 6.75B | 7.43B | 9.16B | 5.62B | Net Income Common Stockholders |
8.89B | 5.05B | 3.79B | 4.54B | 5.59B | 3.21B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.11B | 11.16B | 9.35B | 9.95B | 10.46B | 15.48B | Total Assets |
130.13B | 122.12B | 116.08B | 93.10B | 95.42B | 88.28B | Total Debt |
20.47B | 20.24B | 29.89B | 10.01B | 10.62B | 10.22B | Net Debt |
6.36B | 9.07B | 20.55B | 61.00M | 160.00M | -5.27B | Total Liabilities |
73.19B | 69.95B | 68.21B | 47.57B | 53.21B | 51.55B | Stockholders Equity |
56.94B | 52.17B | 47.87B | 45.53B | 42.21B | 36.73B |
Cash Flow | Free Cash Flow | ||||
0.00 | 13.83B | -18.31B | 1.31B | -4.41B | 2.57B | Operating Cash Flow |
0.00 | 15.94B | -16.71B | 2.60B | -3.68B | 4.63B | Investing Cash Flow |
0.00 | -1.92B | -1.96B | -1.15B | -675.00M | -2.02B | Financing Cash Flow |
0.00 | -12.22B | 18.06B | -1.97B | -664.00M | -1.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | ¥77.25B | 9.40 | 4.36% | 13.19% | 93.10% | ||
69 Neutral | €561.37B | 16.30 | 6.56% | 4.26% | 6.67% | -43.78% | |
64 Neutral | $4.44B | 11.99 | 5.16% | 249.23% | 4.01% | -11.87% | |
64 Neutral | $1.55T | 10.55 | 12.49% | 3.63% | 11.60% | 79.43% | |
61 Neutral | ¥1.45T | 11.53 | 13.61% | 2.56% | 27.41% | 214.53% | |
60 Neutral | $1.06T | 16.29 | 7.47% | 2.36% | -8.60% | 1300.80% | |
57 Neutral | ¥195.82B | 11.16 | 4.43% | -4.62% | 17.56% |